Notice of Meeting, 41400-41401 [05-14183]
Download as PDF
<![CDATA[
41400
Federal Register / Vol. 70, No. 137 / Tuesday, July 19, 2005 / Notices
Regional and Community Bank Group)
101 Market Street, San Francisco,
California 94105-1579:
1. Marianne Boyd Johnson, Las Vegas,
Nevada; to acquire approximately 22.4
percent of the voting shares of Western
Alliance Bancorporation, Las Vegas,
Nevada, and thereby indirectly acquire
voting shares of BankWest of Nevada,
Las Vegas, Nevada, Torrey Pines Bank,
San Diego, California, and Alliance
Bank of Arizona, Phoenix, Arizona.
Board of Governors of the Federal Reserve
System, July 13, 2005.
Robert deV. Frierson,
Deputy Secretary of the Board.
[FR Doc. 05–14167 Filed 7–18–05; 8:45 am]
BILLING CODE 6210–01–S
FEDERAL RESERVE SYSTEM
Change in Bank Control Notices,
Acquisition of Shares of Bank or Bank
Holding Companies; Correction
This notice corrects a notice (FR Doc.
05-13519) published on pages 3977539776 for the issue for Monday, July 11,
2005.
Under the Federal Reserve Bank of St.
Louis heading, the entry for Charles
Hardcastle, Bowling Green, Kentucky, is
revised to read as follows:
A. Federal Reserve Bank of St. Louis
(Glenda Wilson, Community Affairs
Officer) 411 Locust Street, St. Louis,
Missouri 63166-2034:
1. Charles Anderson Hardcastle,
Bowling Green, Kentucky, individually
and as a member of the Hardcastle
Control Group, which also includes
Carolyn Hardcastle, Bowling Green,
Kentucky; Colleen Hardcastle, Oakland,
New Jersey; Cheryl Anderson; Patrick
Anderson; Laura Anderson; and Erin
Anderson; all of Lexington, Kentucky; to
acquire voting shares of Citizens First
Corporation, Bowling Green, Kentucky,
and thereby indirectly acquire Citizens
First Bank, Bowling Green, Kentucky.
Comments on this application must
be received by July 25, 2005.
Board of Governors of the Federal Reserve
System, July 13, 2005.
Robert deV. Frierson,
Deputy Secretary of the Board.
[FR Doc. 05–14168 Filed 7–18–05; 8:45 am]
BILLING CODE 6210–01–S
VerDate jul<14>2003
17:15 Jul 18, 2005
Jkt 205001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Agency For Healthcare Research and
Quality
Dated: July 11, 2005.
Carolyn M. Clancy,
Director.
[FR Doc. 05–14182 Filed 7–18–05; 8:45 am]
BILLING CODE 4160–90–M
Notice of Meeting
In accordance with section 10(d) of
the Federal Advisory Committee Act (5
U.S.C., Appendix 2), announcement is
made of a Health Care Policy and
Research Special Emphasis Panel (SEP)
meeting.
A Special Emphasis Panel is a group
of experts in fields related to health care
research who are invited by the Agency
for Healthcare Research and Quality
(AHRQ), and agree to be available, to
conduct on an as needed basis,
scientific reviews of applications for
AHRQ support. Individual members of
the Panel do not attend regularlyscheduled meetings and do not serve for
fixed terms or a long period of time.
Rather, they are asked to participate in
particular review meetings which
require their type of expertise.
Substantial segments of the upcoming
SEP meeting listed below will be closed
to the public in accordance with the
Federal Advisory Committee Act,
section 10(d) of 5 U.S.C., Appendix 2
and 5 U.S.C. 552b(c)(6). Dissertation
grant application, ‘‘The Economics of
Mother’s Milk Feedings in the Neonatal
Intensive Care Unit’’ is to be reviewed
and discussed at this meeting. These
discussions are likely to reveal personal
information concerning individuals
associated with the application. This
information is exempt from mandatory
disclosure under the above-cited
statutes.
SEP Meeting on: The Economics of
Mother’s Milk Feedings in the Neonatal
Intensive Care Unit.
Date: July 19, 2005 (open on July 19 from
1 p.m. to 1:15 p.m. and closed for the
remainder of the telephone conference call
meeting).
Place: AHRQ, John M. Eisenberg Building,
540 Gaither Road, 2nd Floor Conference
Room, Rockville, Maryland 20850.
Contact Person: Anyone wishing to obtain
a roster of members, agenda or minutes of the
non-confidential portions of this meeting
should contact Mrs. Bonnie Campbell,
Committee Management Officer, Office of
Extramural Research, Education and Priority
Populations, AHRQ, 540 Gaither Road, Room
2038, Rockville, Maryland 20850, telephone
(301) 427–1554.
Agenda items for this meeting are
subject to change as priorities dictate.
This notice is being published less
than 15 days prior to the July 19
meeting, due to the time constraints of
reviews and funding cycles.
PO 00000
Frm 00032
Fmt 4703
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Agency for Healthcare Research and
Quality
Notice of Meeting
In accordance with section 10(d) of
the Federal Advisory Committee Act (5
U.S.C., Appendix 2) announcement is
made of a Health Care Policy and
Research Special Emphasis Panel (SEP)
meeting.
A Special Emphasis Panel is a group
of experts in fields related to health care
research who are invited by the Agency
for Healthcare Research and Quality
(AHRQ), and agree to be available, to
conduct on an as needed basis,
scientific reviews of applications for
AHRQ support. Individual members of
the Panel do not attend regularlyscheduled meetings and do not serve for
fixed terms or a long period of time.
Rather, they are asked to participate in
particular review meetings which
require their type of expertise.
Substantial segments of the upcoming
SEP meeting listed below will be closed
to the public in accordance with the
Federal Advisory Committee Act,
section 10(d) of 5 U.S.C., Appendix 2
and 5 U.S.C. 552b(c)(6). Grant
applications for the Announcement of
Availability of Funds for Grants for
Family Planning Service Delivery
Improvement Research are to be
reviewed and discussed at this meeting.
This program is sponsored by the Office
of Population Affairs. These discussions
are likely to reveal personal information
concerning individuals associated with
the applications. This information is
exempt from mandatory disclosure
under the above-cited statutes.
SEP Meeting on: Announcement of
Availability of Funds for Grants for Family
Planing Service Delivery Improvement
Research.
Date: August 9, 2005 (open on August 9
from 8:15 a.m. and closed for the remainder
of the meeting).
Place: John M. Eisenberg Building, AHRQ
Conference Center, 540 Gaither Road,
Rockville, Maryland 20850.
Contact Person: Anyone wishing to obtain
a roster of members, agenda or minutes of the
non-confidential portions of this meeting
should contact Mrs. Bonnie Campbell,
Committee Management Officer, Office of
Extramural Research, Education and Priority
Populations, AHRQ, 540 Gaither Road, Room
E:\FR\FM\19JYN1.SGM
19JYN1
Federal Register / Vol. 70, No. 137 / Tuesday, July 19, 2005 / Notices
2038, Rockville, Maryland 20850, telephone
(301) 427–1554.
Agenda items for this meeting are
subject to change as priorities dictate.
Dated: July 11, 2005.
Carolyn M. Clancy,
Director.
[FR Doc. 05–14183 Filed 7–18–05; 8:45 am]
BILLING CODE 4160–10–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Single Gene Disorders Resource
Network
Announcement Type: New.
Funding Opportunity Number: AA092.
Catalog of Federal Domestic Assistance
Number: 93.283.
Key Dates:
Letter of Intent (LOI) Deadline: July 29,
2005.
Application Deadline: August 18, 2005.
I. Funding Opportunity Description
Authority: This program is authorized
under Sections 301, 311 and 317(C) of the
Public Health Service Act [42 U.S.C. 241,
243, and 247b–4 as amended].
Background: There are over 6000
known single gene disorders, including
over 1650 with identified genes. Single
gene disorders occur in about one in 300
births, and account for 13 percent of inpatients in pediatric hospital and three
to five percent of pediatric deaths. The
National Center on Birth Defects and
Developmental Disabilities (NCBDDD)
seeks to ensure the optimal outcome of
people with disabling or potential
disabling pediatric single gene
conditions and their families, by
developing surveillance systems that
meet challenges of single gene
disorders, improving screening and
diagnosis, and improving services to
patients and families. Genetic disorders
raise different issues for health care
providers and families than do nongenetic disorders because genetic
disorders have implications for other
family members, and raise psychosocial
issues (such as guilt, blame and
stigmatization). Lessons learned from
public health activities in single gene
disorders can be applied to complex
disorders as their etiologies become
elucidated.
This cooperative agreement will fund
the development of a national resource
network for single gene disorders. Initial
funding will support projects related to
Duchenne and Becker Muscular
Dystrophy (DBMD) and Fragile X
VerDate jul<14>2003
17:15 Jul 18, 2005
Jkt 205001
syndrome (FXS). The proposed National
Network will have the capacity to
expand to other single gene disorders.
Purpose: The purpose of the program
is to develop, implement, and evaluate
a Network for Single Gene Disorders,
focusing specifically on DBMD and
FXS. This program addresses the
‘‘Healthy People 2010’’ focus areas of
Disability and Secondary Conditions;
Mental Health and Mental Health
Disorders; and Maternal, Infant, and
Child Health.’’.
Measurable outcomes of the program
will be in alignment with one (or more)
of the following performance goal(s) for
the National Center on Birth Defects and
Developmental Disabilities (NCBDDD):
Prevent birth defects and developmental
disabilities, and improve the health and
quality of life of Americans with
disabilities.
This announcement is only for nonresearch activities supported by CDC/
ATSDR. If research is proposed, the
application will not be reviewed. For
the definition of research, please see the
CDC Web site at the following Internet
address: https://www.cdc.gov/od/ads/
opspoll1.htm.
Activities:
Applicants may apply for funding
under part A and/or part B. Please note
that if applicants choose to apply for
both part A and part B, applicants may
submit consolidated applications
addressing the requirements of both part
A and part B under one application.
Awardee activities for part A of this
program are as follows:
• Increase access to accurate and
scientifically valid information on the
etiology, diagnosis, and treatment of
DBMD for end users including families,
educators, health professionals, allied
health caregivers, and the general
public. The awardee will specifically
assemble and/or develop informational
materials that: (1) Reflect expert
opinion, evidence-based knowledge and
current clinical practice, and (2)
respond to the needs of individuals and
families affected by DBMD. These
informational materials will be
disseminated to the target populations.
• Assess current educational and
outreach materials related to DBMD
targeted at families with DBMD and the
general public. Develop and/or modify,
implement and evaluate educational
materials for families with DBMD and
the general public, including
information on the etiology, clinical
course, treatment options, and available
services (including services supported
by Health Resources and Services
Administration, the Administration for
Children and Families/Administration
on Developmental Disabilities, and
PO 00000
Frm 00033
Fmt 4703
Sfmt 4703
41401
other DHHS-supported efforts that target
families of children with disabilities).
Content of materials includes issues
specific to single gene disorders, such as
genetic counseling.
• Assess current educational and
outreach materials related to DBMD
targeted at health care providers.
Develop and/or modify, implement and
evaluate educational materials for
providers and students, focusing on
recognition, diagnosis, referral and
treatment. Content of materials includes
current diagnostic and treatment
standards or guidelines; and issues
specific to single gene disorders, such as
genetic counseling.
• Disseminate the information on
DBMD widely within the targeted group
including families, educators, health
professionals, allied health caregivers,
and the general public. This may be new
or existing materials in a variety of
formats including written, video, CD,
and World Wide Web. Ensure the
dissemination plan for the materials is
developed, methods for reaching underserved and minority communities are
described and justified; and accurate
information about diagnosis and
treatment of DBMD is available to
various stakeholders, i.e., practitioners,
families, teachers, and other caregivers.
• Coordinate educational activities
with other community-based and
community-wide providers and
organizations that offer services or
direct education messages to U.S.
residents that have DBMD and their
providers.
• Hire and train staff as necessary to
implement education and outreach
activities for DBMD.
• Increase opportunities for regular
and ongoing DBMD training and
education available to persons within
the targeted audiences.
• Identify core competencies about
DBMD for medical and allied health
students.
• Evaluate the core competencies for
appropriateness and validity based on
needs of the audiences and on scientific
research.
• Develop methods to ensure that
materials and resources for DBMD
education and training are easily
accessible.
• Coordinate activities with other
awardees.
Awardee activities for part B of this
program are as follows:
• Increase access to accurate and
scientifically valid information on the
etiology, diagnosis, and treatment of
FXS for end users including health
professionals, allied health caregivers,
and students. The awardee will
specifically assemble and/or develop
E:\FR\FM\19JYN1.SGM
19JYN1
]]>Agencies
[Federal Register Volume 70, Number 137 (Tuesday, July 19, 2005)]
[Notices]
[Pages 41400-41401]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 05-14183]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Agency for Healthcare Research and Quality
Notice of Meeting
In accordance with section 10(d) of the Federal Advisory Committee
Act (5 U.S.C., Appendix 2) announcement is made of a Health Care Policy
and Research Special Emphasis Panel (SEP) meeting.
A Special Emphasis Panel is a group of experts in fields related to
health care research who are invited by the Agency for Healthcare
Research and Quality (AHRQ), and agree to be available, to conduct on
an as needed basis, scientific reviews of applications for AHRQ
support. Individual members of the Panel do not attend regularly-
scheduled meetings and do not serve for fixed terms or a long period of
time. Rather, they are asked to participate in particular review
meetings which require their type of expertise.
Substantial segments of the upcoming SEP meeting listed below will
be closed to the public in accordance with the Federal Advisory
Committee Act, section 10(d) of 5 U.S.C., Appendix 2 and 5 U.S.C.
552b(c)(6). Grant applications for the Announcement of Availability of
Funds for Grants for Family Planning Service Delivery Improvement
Research are to be reviewed and discussed at this meeting. This program
is sponsored by the Office of Population Affairs. These discussions are
likely to reveal personal information concerning individuals associated
with the applications. This information is exempt from mandatory
disclosure under the above-cited statutes.
SEP Meeting on: Announcement of Availability of Funds for Grants
for Family Planing Service Delivery Improvement Research.
Date: August 9, 2005 (open on August 9 from 8:15 a.m. and closed
for the remainder of the meeting).
Place: John M. Eisenberg Building, AHRQ Conference Center, 540
Gaither Road, Rockville, Maryland 20850.
Contact Person: Anyone wishing to obtain a roster of members,
agenda or minutes of the non-confidential portions of this meeting
should contact Mrs. Bonnie Campbell, Committee Management Officer,
Office of Extramural Research, Education and Priority Populations,
AHRQ, 540 Gaither Road, Room
[[Page 41401]]
2038, Rockville, Maryland 20850, telephone (301) 427-1554.
Agenda items for this meeting are subject to change as priorities
dictate.
Dated: July 11, 2005.
Carolyn M. Clancy,
Director.
[FR Doc. 05-14183 Filed 7-18-05; 8:45 am]
BILLING CODE 4160-10-M
